Evidence map›Paper›PMID 31382438›Full record

ArticleToxins2019

Association of Long-Term Treatment by Botulinum Neurotoxins and Occupational Therapy with Subjective Physical Status in Patients with Post-Stroke Hemiplegia.

Toyohiro Hamaguchi, Masahiro Abo, Kai Murata, Mari Kenmoku, Izumi Yoshizawa, Atsushi Ishikawa, Makoto Suzuki, Naoki Nakaya, Kensuke Taguchi

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Toyohiro HamaguchiDepartment of Rehabilitation Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan.ORCID 0000-0001-5645-0439
Masahiro AboDepartment of Rehabilitation Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan. abo@jikei.ac.jp.ORCID 0000-0001-6701-4974
Kai MurataDepartment of Rehabilitation Medicine, The Jikei University School of Medicine Hospital, Tokyo 105-8461, Japan.
Mari KenmokuDepartment of Rehabilitation Medicine, The Jikei University School of Medicine Hospital, Tokyo 105-8461, Japan.
Izumi YoshizawaDepartment of Rehabilitation Medicine, The Jikei University School of Medicine Hospital, Tokyo 105-8461, Japan.
Atsushi IshikawaDepartment of Rehabilitation Medicine, The Jikei University School of Medicine Hospital, Tokyo 105-8461, Japan.
Makoto SuzukiFaculty of Health Sciences, Tokyo Kasei University, Saitama 350-1398, Japan.
Naoki NakayaDepartment of Rehabilitation, Graduate School of Health Sciences, Saitama Prefectural University, Saitama 343-8540, Japan.
Kensuke TaguchiDepartment of Rehabilitation Medicine, The Jikei University School of Medicine Hospital, Tokyo 105-8461, Japan.ORCID 0000-0003-2089-0672
Jikei University School of Medicine · JPSaitama Prefectural University · JPTokyo Kasei University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The short-term effects of botulinum toxin type A (BoNT-A) treatment in stroke patients with upper limb extremity are well established. This study examined the association between the recovery of motor function of the upper extremity with subjective physical symptoms in outpatients receiving long-term BoNT-A and occupational therapy following stroke. We also investigated the expectations of patients who elected to continue treatment. Forty-seven patients (23 men and 24 women) aged 61 years received BoNT-A treatment more than 20 times. The subjective physical status was analyzed by using the visual analogue scale score through an eight-item questionnaire. Recovery of motor function in the upper extremity was detected by calculating the change (delta) in Fugl-Mayer Assessment (FMA), and ordinal logistic modeling analysis was used to determine the association between the delta-FMA score and the subjective level of agreement for each item. When the ordinal logistic modeling fit was statistically significant, results were interpreted as having logistic probability. The logistic curves discriminating one point (strongly disagree) from five points (strongly agree) were fit in a stepwise fashion. This study suggests that patients receiving long-term BoNT-A treatment and occupational therapy experienced an increased upper extremity mitigation and decreased insomnia after injection, regardless of the recovery of motor function.

Indexed as

Occupational TherapyAgedBotulinum Toxins, Type ACombined Modality TherapyFemaleHemiplegiaHumansMaleMiddle AgedStrokeTreatment OutcomeBotulinum Toxins, Type ABoNT-Amotor functionpost-stroke hemiplegiasubjective physical statusupper extremity

Identifiers

PMID31382438
PMCPMC6723584
OpenAlexW2965344989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.